On a sequential basis, the company exhibited a 3.15 per cent increase in revenue along with EBITDA, which grew 21 per cent year-on-year.
Revenue for India increased by 23 per cent year-on-year, coming to Rs 934 crore.
Commenting on the result, Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare, stated, “In Q2 FY24, our consolidated revenue witnessed an impressive 18 per cent YoY growth, reaching Rs 3,317 crore, attributed to the successful ramp-up of new hospitals initiated in the last two financial years. This growth was further amplified by various cost-saving initiatives, emphasizing our commitment to operational efficiency.
This quarter, the GCC business increased 16 per cent in revenue YoY, reaching Rs 2,383 crore.”
First Published: Nov 15 2023 | 5:31 PM IST